Remove 2017 Remove BioTech Remove Medicare Remove Public Health
article thumbnail

Trust in Healthcare is Under Stress in the US and Globally, Edelman Finds

Health Populi

Year-on-year, different spikes and ups-and-downs call out for special mention, such as: Pharma’s 13-point steep dive to 38% between 2017 and 2018, dramatically recovering by 9 points in the last year to 47% [with the wild card here of whether U.S. to approve Medicare’s negotiation of drug prices with pharmaceutical companies].

BioTech 310
article thumbnail

Spring 2019: Healthcare Updates to Know

Advanced Medical Reviews

Sworn in on May 11, 2017, Gottlieb was known for his efforts to regulate the tobacco and e-cigarette industries, lower drug prices and address the growing opioid crisis. Sharpless is a proponent of big data and previously founded two biotech companies. CMS Publishes New National Health Expenditures Data. percent growth in 2019.

BioTech 66